Product logins

Find logins to all Clarivate products below.


Richard Massey

Director, Medical Writing

Richard leads Clarivate’s Value Communication Centre of Excellence and provides strategic guidance for the team of medical writers and creative designers. Having come from a scientific marketing background, Richard brings an astute commercial perspective to the team. Collaborating with clients in the pharmaceutical and medical device industries, Richard has successfully delivered payer value propositions, objection handlers, evidence dossiers, HTA submissions, publications, and training workshops for Top 10 Pharma brands across a comprehensive range of treatment and domain areas. Richard has considerable experience message testing in major markets. He has hosted workshops on value proposition development, objection handling, payer archetypes and HTA trends, and has developed and presented webinars on a variety of market access topics.

Richard has over 10 years of experience in scientific communication roles. Prior to joining Clarivate, Richard was content lead at a Cambridge-based life science marketing agency, creating collateral for global life science brands. His work has featured in leading trade media publications and has been published by Nature, Scientific American and Chemistry World. Richard has a PhD in Organic Chemistry from Durham University.


arrow_forward
Get in touch with Richard

Latest news

News November 6, 2025
Fujifilm Selects IPfolio from Clarivate

Maximizing the value of intellectual property assets to support business growth London, U.K. November 6, 2025. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that…

News October 30, 2025
Clarivate Pulse of the Library Report Reveals Link Between AI Literacy, AI Implementation and Confidence

Drawing on insights from over 2,000 librarians representing academic, national and public libraries globally, the report offers an up-to-date view of how they are adapting to rapid change London, U.K.,…

News October 29, 2025
Clarivate Reports Third Quarter 2025 Results

— Continued acceleration of organic ACV — — Raises 2025 Revenues Outlook — — Repurchased 11.7 million ordinary shares and repaid $100 million of debt in the third quarter—  …

Related resources

Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center
The trends to watch in 2025 The trends to watch in 2025
Blog January 8, 2025
The trends to watch in 2025